ASAMEDIC AS
Norwegian pharmaceutical company developing life-saving heart attack treatment.
Översikt
- Okänt
- Anställda
- 1.2milj NOK
- Omsättning
- 2013
- Grundat
Nyckelbeslutsfattare
Tom Henrik Sundby
Chief Financial Officer
Brandon Devennie
Vice President, U.S. Strategy & Operations
Geir Ivar Westen
Chief Executive Officer
Lotte Theodorsen
Regulatory Manager
Beskrivning
Asamedic is a Norwegian pharmaceutical company established in 2013. The core mission of the organization is dedicated to saving lives globally. Specifically, Asamedic focuses its research and innovation efforts on developing a novel drug treatment for acute myocardial infarction, commonly known as a...